FDA Inspection 908368 — McGuff Pharmaceuticals, Inc.

McGuff Pharmaceuticals, Inc. — FEI 2022073

The FDA completed an inspection of McGuff Pharmaceuticals, Inc. on December 31, 2014 in Santa Ana, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
December 31, 2014
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Santa Ana, CA (United States)

Citations

IDCFRDescription
191421 CFR 211.166(a)Lack of written stability program
193221 CFR 211.167(a)Sterility/pyrogen-free testing